Anand Padmanabhan Presents a Case Series of HIT Patients with Negative Results in HIT ELISAs
Anand Padmanabhan, Professor and Consultant at Mayo Clinic, shared a post on LinkedIn:
“Excited to present a case series of HIT patients with NEGATIVE results in HIT ELISAs that use targets such as polyvinylsulfonate/PF4 and heparin/PF4, which are the commonest antigens used in HIT diagnostic kits. These antibodies activate platelets, and re-exposure of the patients to heparin based on these negative results ended in platelet counts dropping again, confirming HIT. This study emphasizes the importance of functional testing to make an accurate diagnosis especially in patients with a complex clinical course. I want to acknowledge colleagues from various institutions who contributed cases to this study. Have you seen such patients in your practice? Could this phenomenon be under-recognized?”
Title: Pathogenic PF4/Polyvinylsulfonate ELISA-negative Antibodies in HIT
Authors: Adam J. Kanack, Noah P. Splinter, Emily E. Mauch, Leben Tefera, Morayma Reyes Gil, Sakshi Jasra, Andrew Goodwin, Kristi J Smock, Hadiyah Ahmad, Aneel Ashrani, Nathaniel L. Robinson, Ana I. Casanegra, Curtis G. Jones, Shannon M. Pechauer, Erin Yttre, Richard H. Aster, Mindy C. Kohlhagen, Rachel R. Leger, David L. Murray, Lu Zhou, Demin Wang, Renren Wen, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan
Read full study here.
Stay informed with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin